Addex Therapeutics Ltd (0QNV)
LSE
0.0244
+0.0012 (+5.17%)
Closed
Sep 18, 2026
Day's Range
0.02440.0244
52 wk Range
0.02320.0682
Financial Statements - 0QNV - Addex Therapeutics Ltd
Revenue
35.99M▲ 7.1%
Net Income
810.00K▲ 2.1%Net Margin 2.3%
EBITDA
4.42M▲ 1.0%
Free Cash Flow
2.75M▲ 9.0%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|
| Sales | 35.99M | 33.60M | 31.62M |
| Cost of Goods | 18.59M | 17.94M | 20.55M |
| Gross Profit | 17.40M | 15.66M | 11.06M |
 Operating Expense | - | - | - |
| Operating Income | 1.25M | 1.04M | -5.53M |
| Non-Operating Interest | - | - | - |
| Other Income Expense | - | - | - |
| Pre Tax Income | 928K | 902K | -6.63M |
| Income Tax | 118K | 109K | 144K |
| Net Income | 810K | 793K | -6.77M |
| EPS Basic | 0.06 | 0.06 | -0.510001 |
| EPS Diluted | 0.06 | 0.06 | -0.510001 |
| Basic Shares Outstanding | 14.19M | 14.19M | 13.44M |
| Diluted Shares Outstanding | 14.19M | 14.19M | 13.44M |
| Ebit | - | - | - |
| Ebitda | 4.42M | 4.37M | -1.48M |
| Net Income Continuous Operations | 928K | 902K | -6.63M |
| Minority Interests | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
